Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosylate versus propofol for general anesthesia in day surgery
ChiCTR2000037877Phase 4Recruiting
- Sponsor
- First People's Hospital of Lianyungang City
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of remimazolam in None (2 arms), sponsored by First People's Hospital of Lianyungang City. Primary endpoint: Anesthesia and sedation success rate. Started Sep 2020; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2000037877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000037877.